Pharmaceutical manufacturing and third-party services in India.
Annual revenue $2.9M Latest available
Total funding - Funding intelligence
Employees 64 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Daffohils Laboratories

Daffohils Laboratories is a company. The company has 64 employees as of March 24, 2025. Daffohils Laboratories offers products and services including Tablets and Capsules.

  • Employees 64 as on 24 Mar, 2025
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Social
    Locked
  • Legal Name Daffohils Laboratories Pvt Ltd
  • Jurisdiction Dehradun, Uttarakhand, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $2.87 M (USD)
    -14.82
    as on Mar 31, 2024
  • Net Profit
    $26.56 K (USD)
    25.32
    as on Mar 31, 2024
  • EBITDA
    $139.77 K (USD)
    40.71
    as on Mar 31, 2024
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    64

    as on Mar 24, 2025

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Daffohils Laboratories

Daffohils Laboratories offers a comprehensive portfolio of products and services, including Tablets and Capsules.

Product name locked
Category locked
Primary

Tablets are manufactured for healthcare purposes under certified standards

Product name locked
Category locked
Locked

Capsules are produced for various medicinal applications with adherence to quality protocols

Funding Insights of Daffohils Laboratories

Premium access

Detailed funding history for Daffohils Laboratories

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Daffohils Laboratories

Investments
Premium access

Investment portfolio details for Daffohils Laboratories

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Daffohils Laboratories

Premium access

Detailed financials for Daffohils Laboratories

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Daffohils Laboratories Comparisons

Daffohils Laboratories Primary company
Description
Pharmaceutical manufacturing and third-party services in Ind...
Location
-
Founded Year
-
Annual Revenue
$2.87 M (USD)
Net Profit
$26.56 K (USD)
EBITDA
$139.77 K (USD)
Employees
64
As of 2025
Premium access

Peer comparison for Daffohils Laboratories

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Daffohils Laboratories

Premium access

Detailed competitors of Daffohils Laboratories

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Daffohils Laboratories

Premium access

Complete news archive for Daffohils Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Daffohils Laboratories

As of Mar 24, 2025, the latest employee count at Daffohils Laboratories is 64.

Annual revenue of Daffohils Laboratories is $2.87M as on Mar 31, 2024.

Daffohils Laboratories is recognized as a prominent third-party pharma manufacturer in India, with a focus on providing effective and safe pharmaceutical products. A diverse array of items, including tablets, capsules, syrups, and ointments, is offered by the company, all approved by regulatory bodies such as the State Drug Controller and DCGI. Certifications like WHO-GMP and ISO are maintained, ensuring consistent quality and compliance. The company is noted for its commitment to affordable healthcare solutions and has established partnerships across multiple countries, driven by values of honesty and innovation. Exports to regions like Mali and UAE are facilitated, emphasizing global reach in the pharmaceutical sector. Over 27 years of experience is reflected in its operations, supporting stakeholders through reliable manufacturing practices.

Daffohils Laboratories offers Tablets and Capsules.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available